Medtronic stock

MDT · NYSE · USD

Compare Medtronic
$103.49Change from previous close: +0.61%Absolute change: +$0.62

Close · November 16, 2026

Price history

+7.48% over the period

1 year: from $96.28 (November 17, 2025) to $103.49 (November 16, 2026), +7.48%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026$103.49
October 30, 2026$96.54
September 30, 2026$86.29
August 31, 2026$90.65
July 31, 2026$85.39
June 30, 2026$78.23
May 29, 2026$73.81
April 30, 2026$80.97
March 31, 2026$86.65
February 27, 2026$97.66
January 30, 2026$102.96
December 31, 2025$96.06
November 28, 2025$105.33
November 17, 2025$96.28

At a glance

  • The company

    Develops and manufactures implantable cardiac devices, neurostimulation systems, and surgical instruments for healthcare providers and patients worldwide

  • Latest results

    Quarter to July 31, 2026 · EPS $1.45 (estimate $1.39)

TickerLandia's take on Medtronic

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$73.31
52-wk high$106.33

−2.68% from the 52-week high

Analysts · 30 analysts

Average target$105.00+1.46% vs. price

Buy 19 · Hold 11 · Sell 0 · Buy

TickerLandia Fingerprint: Medtronic

Compared with similar companies: very high dividend.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Medtronic is priced as in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), Medtronic's P/E today is 27.7, in line with the median of its last 10 fiscal years (28.4; between 22.3 and 49.2 from 2017 to 2026). Medtronic's P/E (trailing 12 months): 25.4, −19% against the median of a group of 11 similar companies (31.4).

P/E compared with its history

Compared with 11 similar companies

Medtronic's metrics compared with similar companies
MetricMedtronicPosition in the groupBand
P/E (trailing 12 months)25.4Middle
Forward P/E16.1Middle
Operating margin20.1%Middle
ROE10.6%Middle
Debt/equity0.55Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Medtronic. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$9.76B

Latest quarter · Q to Jul 2026

Net income

$1.47B

Latest quarter · Q to Jul 2026

Quarterly net margin

15.1%

Latest quarter · Q to Jul 2026

Numbers and valuation

Full valuation
Market cap
$132.22B
P/E
25.4
EPS
$4.07
Volume
1.22M
Daily trading
€789.75M
Dividend yield
2.76%
Last ex-dividend on September 25, 2026

How Medtronic is changing

All results
  • Revenue grew 3.8% a year on average over the last 5 years

  • Profits turn into cash: free cash flow equal to 120% of net income

  • Shares outstanding down 4.9% in 5 years

Returns

Medtronic returns with dividends

$1,000 invested in Medtronic 5 years ago, on November 16, 2021, would be worth $1,029 today with dividends reinvested: +2.90% in total, +0.57% per year. On price alone it would be $877 (−12.29%).

PeriodMedtronicS&P 500$1,000 becomes
1 month+9.22%−3.12%$1,092
6 months+35.90%+2.07%$1,359
Year to date+7.73%+10.46%$1,077
1 year+11.02%+13.33%$1,110
3 years+52.43%+67.73%$1,524
5 years+2.90%+60.86%$1,029
10 years+66.52%+247.35%$1,665

Over the last 6 months it has done better than 72% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Medtronic: technical analysis

Medtronic shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 23.4% below its highest close since January 2, 1990 ($135.17, September 8, 2021).

Trend
No clear trend
RSI (14 sessions)
65
Between 30 and 70
vs 200-session average
+17.25%

Support and resistance

Price areas where Medtronic has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$106.01+2.44%3 touches, last on November 5, 2026
  2. Last price$103.49
  3. Support$95.20−8.01%6 touches, last on September 15, 2026
  4. Support$89.44−13.57%5 touches, last on September 11, 2026
  5. Support$85.34−17.53%5 touches, last on October 1, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
0.15
Volatility (60 sessions, annualised)
27.3%
Largest fall in the last year
−30.00%

In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Medtronic: seasonality

Average monthly price change over 37 years

+2.1%Jan−1.4%Feb−0.1%Mar+0.2%Apr+2.1%May+1.0%Jun+1.6%Jul+1.5%Aug+1.0%Sep+0.9%Oct+2.2%Nov+2.3%Dec

Over the last 37 years, the strongest month for Medtronic has been December: +2.30% on average, positive in 22 years out of 36. The weakest has been February: −1.36% on average, positive in 16 years out of 37. November, the current month, has been positive in 22 years out of 36 (+2.24% on average).

Show chart data
MonthAverageMedianPositive years
January+2.14%+1.05%21 of 36
February−1.36%−1.06%16 of 37
March−0.08%+0.41%20 of 37
April+0.17%−0.11%18 of 37
May+2.08%+1.68%25 of 37
June+0.95%+0.90%19 of 37
July+1.63%+2.09%25 of 37
August+1.55%+3.15%24 of 37
September+1.00%+0.68%19 of 37
October+0.87%+0.26%19 of 37
November+2.24%+2.14%22 of 36
December+2.30%+2.37%22 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Medtronic and its competitors

Headquartered in Galway, Ireland, Medtronic plc was founded in 1949 and sells medical technology across three areas. Its cardiovascular range includes pacemakers, defibrillators, heart valves, and remote monitoring software, while its neuroscience offering covers spinal cord stimulation, brain modulation, and implantable drug infusion systems. The medical and surgical portfolio spans surgical stapling, robotic-assisted surgery, hernia and gynecology products, and insulin pumps with continuous glucose monitoring.

Headquarters
Galway, Ireland
Employees
95,000
Founded
1949
Chief executive
Geoffrey Martha
Medtronic and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
MedtronicMDT$132.22B20.1%25.4+35.90%
StrykerSYK$117.88B24.0%33.0+1.41%
Abbott LaboratoriesABT$187.95B15.6%40.5+28.26%
Boston ScientificBSX$64.27B19.6%18.7−16.65%
Edwards LifesciencesEW$61.61B28.8%61.6+31.31%
GE HealthCare TechnologiesGEHC$37.8B13.8%17.7+37.99%

Same industry or related industries, similar size. Compare Medtronic with its competitors · Full profile